SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-20-002274
Filing Date
2020-01-31
Accepted
2020-01-31 16:27:07
Documents
4
Period of Report
2020-03-06
Effectiveness Date
2020-01-31

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a0120_relmadatherap.htm DEF 14A 1037369
2 GRAPHIC relmada_logo.jpg GRAPHIC 83632
3 GRAPHIC proxy001.jpg GRAPHIC 666676
4 GRAPHIC proxy002.jpg GRAPHIC 406547
  Complete submission text file 0001213900-20-002274.txt   2581521
Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39082 | Film No.: 20565426
SIC: 2834 Pharmaceutical Preparations